Biolux Technology, a pioneer in orthodontic optimization, has proudly announced the U.S. launch of OrthoPulse, its flagship product and platform. This updated version, OrthoPulse 2.0, boasts enhanced features and improved reliability, backed by extensive clinical evidence. The launch represents a significant step forward for Biolux as it continues to innovate within the dental and orthodontic sectors.
OrthoPulse 2.0 introduces state-of-the-art technology that enhances both practitioner and patient experiences. Its effectiveness and safety in orthodontic treatment are reinforced by substantial clinical validation, making it a preferred choice, particularly in complex adult aligner treatments.
Dr. Leone Paola, endorsing OrthoPulse, stated, “We have successfully treated numerous patients with OrthoPulse, resulting in significantly fewer refinements. We highly recommend this innovative technology as a standard of care.”
Driving this initiative forward in the U.S. market is Michael Hendricks, appointed as Chief Business Officer for North America. Hendricks brings a wealth of experience and a dedication to excellence, emphasizing Biolux’s commitment to setting new standards in orthodontic care with advanced accelerated technology.
“We are excited to introduce OrthoPulse 2.0 to the U.S. market,” commented Michael Hendricks. “Our enhanced product, combined with robust clinical evidence, positions us well to support our partner doctors and advance orthodontic practices.
We are eager to establish our presence and foster strong relationships with clinicians.”
OrthoPulse utilizes photobiomodulation, a low-level light energy technology, to stimulate bone around tooth roots, facilitating faster and more predictable tooth movement for both aligner and bracket patients. This non-invasive treatment option offers patients the benefits of accelerated, comfortable orthodontic care.